2023 Q3 Form 10-Q Financial Statement
#000180620123000108 Filed on August 09, 2023
Income Statement
Concept | 2023 Q3 | 2023 Q2 |
---|---|---|
Revenue | $26.01M | $38.15M |
YoY Change | -48.67% | -26.69% |
Cost Of Revenue | $5.369M | $6.117M |
YoY Change | 3.27% | 20.29% |
Gross Profit | $20.64M | $32.04M |
YoY Change | -54.61% | -31.78% |
Gross Profit Margin | 79.35% | 83.97% |
Selling, General & Admin | $14.38M | $15.19M |
YoY Change | -6.09% | 26.98% |
% of Gross Profit | 69.7% | 47.41% |
Research & Development | $1.717M | $1.128M |
YoY Change | -27.09% | -48.45% |
% of Gross Profit | 8.32% | 3.52% |
Depreciation & Amortization | $300.0K | $252.0K |
YoY Change | 354.55% | -18.71% |
% of Gross Profit | 1.45% | 0.79% |
Operating Expenses | $16.10M | $16.32M |
YoY Change | -8.88% | 15.31% |
Operating Profit | $4.536M | $15.72M |
YoY Change | -83.68% | -52.09% |
Interest Expense | $2.799M | $2.655M |
YoY Change | 74.07% | 136.21% |
% of Operating Profit | 61.71% | 16.89% |
Other Income/Expense, Net | -$3.000K | -$6.000K |
YoY Change | -98.74% | |
Pretax Income | $4.535M | $15.51M |
YoY Change | -82.73% | -51.08% |
Income Tax | $1.500M | $4.100M |
% Of Pretax Income | 33.08% | 26.43% |
Net Earnings | $3.003M | $11.37M |
YoY Change | -87.76% | -50.83% |
Net Earnings / Revenue | 11.55% | 29.8% |
Basic Earnings Per Share | $0.02 | $0.09 |
Diluted Earnings Per Share | $0.02 | $0.09 |
COMMON SHARES | ||
Basic Shares Outstanding | 120.7M shares | 120.7M shares |
Diluted Shares Outstanding | 121.3M shares | 121.5M shares |
Balance Sheet
Concept | 2023 Q3 | 2023 Q2 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $232.6M | $224.4M |
YoY Change | 15.26% | 33.84% |
Cash & Equivalents | $232.6M | $224.4M |
Short-Term Investments | ||
Other Short-Term Assets | $3.137M | $2.980M |
YoY Change | -10.75% | -10.81% |
Inventory | ||
Prepaid Expenses | ||
Receivables | $5.266M | $6.329M |
Other Receivables | $9.200M | $11.76M |
Total Short-Term Assets | $293.9M | $284.5M |
YoY Change | 3.76% | 9.82% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $3.713M | $3.013M |
YoY Change | 33.13% | 7.95% |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $5.539M | $5.626M |
YoY Change | 1106.75% | 3601.32% |
Total Long-Term Assets | $89.52M | $102.3M |
YoY Change | -22.66% | -5.07% |
TOTAL ASSETS | ||
Total Short-Term Assets | $293.9M | $284.5M |
Total Long-Term Assets | $89.52M | $102.3M |
Total Assets | $383.4M | $386.8M |
YoY Change | -3.91% | 5.45% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $221.0K | $30.00K |
YoY Change | 20.77% | -92.87% |
Accrued Expenses | $9.302M | $7.491M |
YoY Change | 5.25% | 22.7% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | $3.750M | $3.750M |
YoY Change | 0.0% | -3.99% |
Total Short-Term Liabilities | $19.97M | $17.97M |
YoY Change | 17.63% | 28.21% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $141.1M | $142.0M |
YoY Change | -2.31% | 0.73% |
Other Long-Term Liabilities | $3.926M | $3.923M |
YoY Change | -7.21% | -10.25% |
Total Long-Term Liabilities | $145.1M | $145.9M |
YoY Change | 0.41% | 3.51% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $19.97M | $17.97M |
Total Long-Term Liabilities | $145.1M | $145.9M |
Total Liabilities | $168.7M | $167.7M |
YoY Change | 1.79% | 5.21% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$188.9M | -$191.9M |
YoY Change | -10.74% | -18.74% |
Common Stock | $1.282M | $1.282M |
YoY Change | 0.0% | 0.0% |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $214.7M | $219.2M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $383.4M | $386.8M |
YoY Change | -3.91% | 5.45% |
Cashflow Statement
Concept | 2023 Q3 | 2023 Q2 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | $3.003M | $11.37M |
YoY Change | -87.76% | -50.83% |
Depreciation, Depletion And Amortization | $300.0K | $252.0K |
YoY Change | 354.55% | -18.71% |
Cash From Operating Activities | $20.30M | $16.07M |
YoY Change | -35.37% | -25.79% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $0.00 | $41.00K |
YoY Change | -100.0% | -123.03% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | -$700.0K | -$467.0K |
YoY Change | ||
Cash From Investing Activities | -$800.0K | -$508.0K |
YoY Change | 193.04% | 185.39% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | -10.90M | -1.083M |
YoY Change | -474.31% | 34.53% |
NET CHANGE | ||
Cash From Operating Activities | 20.30M | 16.07M |
Cash From Investing Activities | -800.0K | -508.0K |
Cash From Financing Activities | -10.90M | -1.083M |
Net Change In Cash | 8.600M | 14.48M |
YoY Change | -74.74% | -29.95% |
FREE CASH FLOW | ||
Cash From Operating Activities | $20.30M | $16.07M |
Capital Expenditures | $0.00 | $41.00K |
Free Cash Flow | $20.30M | $16.03M |
YoY Change | -35.93% | -26.58% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
23154000 | usd |
CY2022Q1 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
-39000 | usd |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
183378000 | usd |
CY2022Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
988000 | usd |
CY2022Q2 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
-24000 | usd |
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
23126000 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
207468000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
23909000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
46280000 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
4163000 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2269000 | usd | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
496000 | usd | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
447000 | usd | |
us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
210000 | usd | |
us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
167000 | usd | |
us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
305000 | usd | |
us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
285000 | usd | |
us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-6000 | usd | |
us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
0 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
608000 | usd | |
us-gaap |
Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
|
-15775000 | usd | |
us-gaap |
Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
|
-6208000 | usd | |
us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
633000 | usd | |
us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-1477000 | usd | |
us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
-259000 | usd | |
us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
-885000 | usd | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
857000 | usd | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
2094000 | usd | |
us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-2133000 | usd | |
us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-2964000 | usd | |
us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-272000 | usd | |
us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-240000 | usd | |
us-gaap |
Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
|
1263000 | usd | |
us-gaap |
Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
|
-13000 | usd | |
us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
718000 | usd | |
us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-105000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
45579000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
53587000 | usd | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
77000 | usd | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
70000 | usd | |
us-gaap |
Payments To Develop Software
PaymentsToDevelopSoftware
|
766000 | usd | |
us-gaap |
Payments To Develop Software
PaymentsToDevelopSoftware
|
294000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-843000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-364000 | usd | |
us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
1875000 | usd | |
us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
1562000 | usd | |
us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
21323000 | usd | |
us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
0 | usd | |
us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
275000 | usd | |
us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
63000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-23473000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-1625000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
21263000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
51598000 | usd | |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
229782000 | usd |
CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
171107000 | usd |
us-gaap |
Interest Paid Net
InterestPaidNet
|
4974000 | usd | |
us-gaap |
Interest Paid Net
InterestPaidNet
|
1756000 | usd | |
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
8726000 | usd | |
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
20853000 | usd | |
us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
0 | usd | |
us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
21000 | usd | |
lpro |
Accrued Intangible Assets Costs
AccruedIntangibleAssetsCosts
|
42000 | usd | |
lpro |
Accrued Intangible Assets Costs
AccruedIntangibleAssetsCosts
|
0 | usd | |
lpro |
Capitalized Software Development Costs Accrued But Not Paid
CapitalizedSoftwareDevelopmentCostsAccruedButNotPaid
|
59000 | usd | |
lpro |
Capitalized Software Development Costs Accrued But Not Paid
CapitalizedSoftwareDevelopmentCostsAccruedButNotPaid
|
27000 | usd | |
lpro |
Accrued Excise Tax From Share Repurchases
AccruedExciseTaxFromShareRepurchases
|
190000 | usd | |
lpro |
Accrued Excise Tax From Share Repurchases
AccruedExciseTaxFromShareRepurchases
|
0 | usd | |
us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | segment | |
us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
Concentrations of revenue and credit risks<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s two largest insurance carrier partners accounted for 34% and 10% of the Company’s total revenue during the three months ended June 30, 2023, and 34% and 11% during the six months ended June 30, 2023, respectively. The Company’s three largest insurance carrier partners accounted for 38%, 11% and 11% of the Company's total revenue during the three months ended June 30, 2022 and 38%, 13% and 10% during the six months ended June 30, 2022, respectively. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents, restricted cash, accounts receivable and contract assets to the extent of the amounts recorded on the balance sheets.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents are deposited in commercial analysis accounts, money market funds and U.S. Treasury securities at financial institutions with high credit standing. Restricted cash relates to funds held by the Company on behalf of the insurance carriers, delegated for the use of insurance claim payments. Restricted cash is deposited in commercial analysis accounts at one financial institution. At times, such deposits may be in excess of the Federal Deposit Insurance Corporation insurance limits of $250,000 per institution. The Company has not experienced any losses on its deposits of cash and cash equivalents and management believes the Company is not exposed to significant risks on such accounts.</span></div>The Company’s accounts receivable and contract assets are derived from revenue earned from customers. The Company maintains an allowance for expected credit losses, which represents an estimate based primarily on market implied lifetime probabilities of default and loss severities for assets with similar risk characteristics. As these inputs are derived from market observations, they inherently include forward-looking expectations about macro-economic conditions. The allowance is evaluated quarterly by the Company for adequacy by taking into consideration factors such as reasonableness of the market implied loss statistics, historical lifetime loss data and credit quality of the customer base. Provisions for the allowance for expected credit losses attributable to bad debt are recorded as general and administrative expenses. Account balances deemed uncollectible are written off, net of actual recoveries. If circumstances related to specific customers change, the Company’s estimate of the recoverability of its contract asset could be further adjusted. The Company does not have any material accounts receivable or contract assets receivable balances that are past due and has not written off any balances in its portfolio for the periods presented. | ||
CY2023Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
100000 | usd |
CY2022Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
100000 | usd |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the unaudited condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates, and those differences may be material. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to estimates are recognized prospectively.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most significant items subject to such estimates and assumptions include, but are not limited to, profit share revenue recognition and the corresponding impact on contract assets, the recognition of the valuations of share-based compensation arrangements and assessing the realizability of deferred tax assets. The Company bases its estimates on historical trends and relevant assumptions that it believes to be reasonable under the circumstances. Accordingly, actual results could be materially different from those estimates.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with profit share revenue recognition and the estimation of contract assets, the Company uses a forecast model to estimate variable consideration based on undiscounted expected future profit share to be received from the insurance carriers. The forecast model projects loan-level earned premiums and insurance claim payments driven by projections of prepayment rate, loan default rate and severity of loss. These assumptions are derived from an analysis of the historical performance of the active loan portfolio, prevailing default and prepayment trends, and macroeconomic projections. Estimates of variable consideration generated by the forecast model are constrained to the extent that it is probable that a significant reversal of revenue will not occur in future periods.</span></div>The Company continually assesses the default and prepayment assumptions of the forecast model against reported performance and lender delinquency data. The forecast model is updated to align the default and prepayment rate projections with actual experience. | ||
CY2023Q1 | us-gaap |
Contract With Customer Asset Net
ContractWithCustomerAssetNet
|
65942000 | usd |
CY2023Q2 | us-gaap |
Contract With Customer Asset Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerAssetIncreaseDecreaseForContractAcquiredInBusinessCombination
|
39328000 | usd |
CY2023Q2 | us-gaap |
Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
|
-1174000 | usd |
CY2023Q2 | us-gaap |
Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
|
18623000 | usd |
CY2023Q2 | lpro |
Payments Received From Insurance Carriers
PaymentsReceivedFromInsuranceCarriers
|
25801000 | usd |
CY2023Q2 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
17000 | usd |
CY2022Q4 | us-gaap |
Contract With Customer Asset Net
ContractWithCustomerAssetNet
|
75430000 | usd |
us-gaap |
Contract With Customer Asset Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerAssetIncreaseDecreaseForContractAcquiredInBusinessCombination
|
76975000 | usd | |
us-gaap |
Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
|
-460000 | usd | |
us-gaap |
Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
|
36200000 | usd | |
lpro |
Payments Received From Insurance Carriers
PaymentsReceivedFromInsuranceCarriers
|
56111000 | usd | |
us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
-21000 | usd | |
CY2023Q2 | us-gaap |
Contract With Customer Asset Net
ContractWithCustomerAssetNet
|
59655000 | usd |
CY2023Q2 | us-gaap |
Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
|
33700000 | usd |
CY2022Q4 | us-gaap |
Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
|
54400000 | usd |
CY2023Q2 | us-gaap |
Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
|
26000000 | usd |
CY2022Q4 | us-gaap |
Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
|
21000000 | usd |
CY2023Q2 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
1453000 | usd |
CY2022Q4 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
1630000 | usd |
CY2023Q2 | us-gaap |
Long Term Debt
LongTermDebt
|
145734000 | usd |
CY2022Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
147433000 | usd |
CY2023Q2 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
3750000 | usd |
CY2022Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
3750000 | usd |
CY2023Q2 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
141984000 | usd |
CY2022Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
143683000 | usd |
CY2022Q3 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
300000000 | usd |
CY2022Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
8600000 | usd |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
16900000 | usd | |
CY2022Q2 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.271 | |
us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.267 | ||
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
23909000 | usd | |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
46280000 | usd | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
121878503 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
126218710 | shares | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.20 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.37 | ||
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
11371000 | usd |
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
23126000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
23909000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
46280000 | usd | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
121878503 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
126218710 | shares | |
us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
578062 | shares | |
us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
405 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
122456565 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
126219115 | shares | |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.20 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.37 | ||
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
613623 | shares | |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
963344 | shares | |
CY2023Q2 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
176443000 | usd |
CY2022Q4 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
187426000 | usd |
CY2023Q2 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2023Q2 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2023Q2 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false | |
CY2023Q2 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false |